About Opthalmology Research Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Opthalmology Research Office
During the past decade, Opthalmology Research Office conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
2010-01-01
2013-11-01
Completed
512
Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
2011-04-22
2013-02-20
Completed
42
Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma
2012-01-01
2019-05-01
Completed
120
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia
2009-12-01
2016-10-01
Completed
85
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
2013-07-02
2018-10-11
Completed
114
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
2014-01-11
2019-10-03
Completed
95
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
2013-07-01
2015-09-01
Completed
53
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Opthalmology Research Office"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Opthalmology Research Office
According to Clinical.Site data, the most researched conditions in "Opthalmology Research Office" are
"Central Retinal Vein Occlusion" (1 trials), "Hemiretinal Vein Occlusion" (1 trials), "Macular Edema" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Opthalmology Research Office" in a lesser frequency.
Clinical Trials Intervention Types at Opthalmology Research Office
Most popular intervention types in "Opthalmology Research Office" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Opthalmology Research Office
The vast majority of trials in "Opthalmology Research Office" are
2 trials for "All" genders.
Clinical Trials Status at Opthalmology Research Office
Currently, there are NaN active trials in "Opthalmology Research Office".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Opthalmology Research Office,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Opthalmology Research Office, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".